<?xml version="1.0" ?>
<document id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb">
  <chunk id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c0" text="Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate HHS Public Access"/>
  <chunk id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1" text="From 2002 to 2003, a global pandemic of severe acute respiratory syndrome (SARS) spread to 5 continents and caused 8000 respiratory infections and 800 deaths. To ameliorate the effects of future outbreaks as well as to prepare for biodefense, a process for the production of a recombinant protein vaccine candidate is under development. Previously, we reported the 5 L scale expression and purification of a promising recombinant SARS vaccine candidate, RBD219-N1, the 218-amino acid residue receptor-binding domain (RBD) of SARS coronavirus expressed in yeast-Pichia pastoris X-33. When adjuvanted with aluminum hydroxide, this protein elicited high neutralizing antibody titers and high RBD-specific antibody titers. However, the yield of RBD219-N1 (60 mg RBD219-N1 per liter of fermentation supernatant; 60 mg/L FS) still required improvement to reach our target of &gt;100 mg/L FS. In this study, we optimized the 10 L scale production process and increased the fermentation yield 6-to 7-fold to 400 mg/ L FS with purification recovery &gt;50%. A panel of characterization tests indicated that the process is reproducible and that the purified, tag-free RBD219-N1 protein has high purity and a well-defined This is an open access article under the CC BY license structure and is therefore a suitable candidate for production under current Good Manufacturing Practice and future phase-1 clinical trials.">
    <entity charOffset="40-46" id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e0" ontology_id="HP_0012828" text="severe" type="phenotype"/>
    <entity charOffset="47-52" id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e1" ontology_id="HP_0011009" text="acute" type="phenotype"/>
    <entity charOffset="120-142" id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e2" ontology_id="HP_0011947" text="respiratory infections" type="phenotype"/>
    <entity charOffset="664-672" id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e3" ontology_id="GO_0003823" text="antibody" type="gene_function"/>
    <entity charOffset="664-672" id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e4" ontology_id="GO_0042571" text="antibody" type="gene_function"/>
    <entity charOffset="702-710" id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e5" ontology_id="GO_0003823" text="antibody" type="gene_function"/>
    <entity charOffset="702-710" id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e6" ontology_id="GO_0042571" text="antibody" type="gene_function"/>
    <entity charOffset="781-793" id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e7" ontology_id="GO_0006113" text="fermentation" type="gene_function"/>
    <entity charOffset="963-975" id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e8" ontology_id="GO_0006113" text="fermentation" type="gene_function"/>
    <pair e1="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e0" e2="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e3" id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.p0" relation="true"/>
    <pair e1="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e0" e2="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e4" id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.p1" relation="true"/>
    <pair e1="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e0" e2="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e5" id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.p2" relation="true"/>
    <pair e1="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e0" e2="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e6" id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.p3" relation="true"/>
    <pair e1="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e0" e2="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e7" id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.p4" relation="true"/>
    <pair e1="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e0" e2="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e8" id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.p5" relation="true"/>
    <pair e1="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e1" e2="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e3" id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.p6" relation="true"/>
    <pair e1="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e1" e2="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e4" id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.p7" relation="true"/>
    <pair e1="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e1" e2="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e5" id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.p8" relation="true"/>
    <pair e1="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e1" e2="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e6" id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.p9" relation="true"/>
    <pair e1="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e1" e2="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e7" id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.p10" relation="true"/>
    <pair e1="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e1" e2="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e8" id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.p11" relation="true"/>
    <pair e1="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e2" e2="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e3" id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.p12" relation="true"/>
    <pair e1="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e2" e2="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e4" id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.p13" relation="true"/>
    <pair e1="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e2" e2="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e5" id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.p14" relation="true"/>
    <pair e1="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e2" e2="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e6" id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.p15" relation="true"/>
    <pair e1="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e2" e2="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e7" id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.p16" relation="true"/>
    <pair e1="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e2" e2="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.e8" id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c1.p17" relation="true"/>
  </chunk>
  <chunk id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c2" text="In our previous study, 13 we had developed a production process to express and purify several tag-free recombinant RBD constructs in yeast and had identified one of the yeast-expressed RBDs, RBD219-N1 (residues 319-536), as a promising SARS vaccine candidate due to its Chen et al."/>
  <chunk id="f63338a20d7b3df2c60068dddfb9086ece7ba5fb.c3" text="Purified RBD219-N1 was diluted with deionized water to a final concentration of 0.3-0.4 mg/mL and analyzed by circular dichroism (CD) on a Jasco-810 spectropolarimeter (Easton, MD) with a 6-position Peltier temperature controller. The CD spectra were obtained from 260 to 185 nm with the Jasco J-1500s spectrophotometer set at 100 nm/min and a response time of 1 s at 25Â°C. The obtained CD data were analyzed using CDPro software by comparing to the reference sets (SP43, SP37, SDP48, and SDP42) using 2 data-fitting programs (CONTIN and CDSSTR). The analyzed secondary structure was also compared with the secondary structure predicted by Phyre2 (Protein Homology/analogY Recognition Chen et al."/>
</document>
